SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+5.87%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$671M
AUM Growth
+$671M
(-4.5%)
Cap. Flow
-$75.2M
Cap. Flow
% of AUM
-11.21%
Top 10 Holdings %
Top 10 Hldgs %
36.87%
Holding
176
New
35
Increased
31
Reduced
45
Closed
50
Top Buys
| 1 |
Biogen
BIIB
|
$20.5M |
| 2 |
CELG
Celgene Corp
CELG
|
$10.4M |
| 3 |
CXRX
Concordia International Corp. Common Stock
CXRX
|
$9.03M |
| 4 |
BCOM
B Communications Ltd
BCOM
|
$6.45M |
| 5 |
CYNA
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
|
$5.32M |
Top Sells
| 1 |
ENDP
Endo International plc
ENDP
|
$18.8M |
| 2 |
Perrigo
PRGO
|
$16.3M |
| 3 |
Teva Pharmaceuticals
TEVA
|
$13.3M |
| 4 |
ASPX
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
|
$12.5M |
| 5 |
Amgen
AMGN
|
$9.21M |
Sector Composition
| 1 | Healthcare | 77.22% |
| 2 | Technology | 6.01% |
| 3 | Utilities | 2.06% |
| 4 | Industrials | 1.46% |
| 5 | Consumer Discretionary | 1.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Wabtec
WAB
$33.1B
| $2.11M | 0.21% | 22,365 +865 | +4% | +$81.5K |
|
102
Aldeyra Therapeutics
ALDX
$351M
| $2.06M | 0.2% | 265,000 +150,000 | +130% | +$1.16M |
|
103
Rocket Pharmaceuticals
RCKT
$354M
| $1.86M | 0.18% | 380,000 -20,000 | -5% | -$98K |
|
104
Charter Communications
CHTR
$36.3B
| $1.72M | 0.17% | +10,065 | New | +$1.72M |
|
|
TW
105
DELISTED
TOWERS WATSON & CO COM STK CL A (DE)
TW
| $1.61M | 0.16% | 12,807 -25,493 | -67% | -$3.21M |
|
106
Exelixis
EXEL
$10.1B
| $1.5M | 0.15% | 400,000 -100,000 | -20% | -$376K |
|
|
APTO
107
DELISTED
Aptose Biosciences, Inc.
APTO
| $1.42M | 0.14% | +221,096 | New | +$1.42M |
|
|
BRCM
108
DELISTED
BROADCOM CORP CL-A
BRCM
| $1.28M | 0.13% | 24,894 -75,906 | -75% | -$3.91M |
|
109
VF Corp
VFC
$5.91B
| $1.23M | 0.12% | 17,600 -24,570 | -58% | -$1.71M |
|
110
Nice
NICE
$8.73B
| $1.16M | 0.11% | +18,250 | New | +$1.16M |
|
|
IMMU
111
DELISTED
Immunomedics Inc
IMMU
| $995K | 0.1% | 245,000 -55,000 | -18% | -$223K |
|
|
GNVC
112
DELISTED
GenVec, Inc.
GNVC
| $735K | 0.07% | 360,325 -168,000 | -32% | -$343K |
|
|
IPXL
113
DELISTED
Impax Laboratories, Inc.
IPXL
| $689K | 0.07% | 15,000 -85,000 | -85% | -$3.9M |
|
114
Sapiens International
SPNS
$2.4B
| $586K | 0.06% | 56,420 | – | – |
|
|
TVRD
115
Tvardi Therapeutics, Inc. Common Stock
TVRD
$281M
| $567K | 0.06% | +46,700 | New | +$567K |
|
116
Galectin Therapeutics
GALT
$274M
| $560K | 0.05% | 205,000 -245,000 | -54% | -$669K |
|
|
ZSAN
117
DELISTED
Zosano Pharma Corporation
ZSAN
| $452K | 0.04% | 62,300 -122,319 | -66% | -$887K |
|
|
CYTO
118
DELISTED
Altamira Therapeutics Ltd. Common Shares 0.01 SF (Bermuda)
CYTO
| $316K | 0.03% | 63,967 -122,333 | -66% | -$604K |
|
|
119
Perrigo
PRGO
$3.27B
| $246K | 0.02% | 273 -18,127 | -99% | -$16.3M |
|
|
CNCE
120
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $236K | 0.02% | 15,858 -359,142 | -96% | -$5.34M |
|
|
TTHI
121
DELISTED
TRANSITION THERAPEUTICS INC (CANADA)
TTHI
| $148K | 0.01% | 70,273 -202,633 | -74% | -$427K |
|
122
Celldex Therapeutics
CLDX
$1.47B
| – | – | -105,000 | Closed | -$2.93M |
|
|
CLLS
123
Cellectis
CLLS
$258M
| – | – | -50,000 | Closed | -$1.73M |
|
124
CVS Health
CVS
$92.8B
| – | – | -42,260 | Closed | -$4.36M |
|
125
Eledon Pharmaceuticals
ELDN
$155M
| – | – | -146,341 | Closed | -$1.65M |
|